Pneumonia Therapeutics Market - Global Industry Analysis

Pneumonia Therapeutics Market

Pneumonia Therapeutics Market by Therapeutics (Prevention Vaccines and Treatment Drugs) and by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 07-Mar-2019 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-3894 Status : Published

Global pneumonia therapeutics market expected to reach approximately USD 23.99 billion by 2025, at a CAGR of around 8.1% between 2019 and 2025. The global pneumonia therapeutics market is growing due to increasing air pollution and rising geriatric population across the globe.

Description

The report covers a forecast and an analysis of the pneumonia therapeutics market on a global and regional level. The study provides historical data for 2016, 2017, and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the pneumonia therapeutics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the pneumonia therapeutics market on a global level.

This report offers a comprehensive view of the global pneumonia therapeutics market along with market trends, drivers, and restraints. This report includes a detailed competitive scenario and portfolio of the key vendors. To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the market has also been included. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Pneumonia Therapeutics Market

The study provides a decisive view of the pneumonia therapeutics market by segmenting it based on therapeutics, distribution channel, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. By therapeutics, the market includes prevention vaccines and treatment drugs. The distribution channel segment includes hospital pharmacy, retail pharmacy, and online pharmacy. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. These regions are further segmented into the U.S., Canada, Germany, UK, France, China, Italy, Japan, India, and Brazil.

Some key participants operating in the global pneumonia therapeutics market include GlaxoSmithKline, Sanofi, Merck & Co. Inc., Novartis AG, Eli Lilly and Company, AstraZeneca, Merck & Co., Pfizer, Baxter International Inc., Allergan, and Lupin Pharmaceuticals Inc., among others.

This report segments the global pneumonia therapeutics market into:

Global Pneumonia Therapeutics Market: Therapeutics Analysis

  • Prevention Vaccines
  • Treatment Drugs

Global Pneumonia Therapeutics Market: Distribution Channel Analysis

  • Hospital pharmacy
  • Retail pharmacy
  • Online pharmacy

Global Pneumonia Therapeutics Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report Description And Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Pneumonia Therapeutics Market, 2016-2025 (USD Billion)
    • 2.2. Global Pneumonia Therapeutics Market: Snapshot
  •  
  • Chapter 3. Pneumonia Therapeutics Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Value Chain Analysis
    • 3.3. Market Drivers
      • 3.3.1. Increasing Prevalence Of Pneumococcal Disease
      • 3.3.2. Increasing Awareness
    • 3.4. Global Pneumonia Therapeutics market Restraints: Impact Analysis
      • 3.4.1. Very low therapy accessibility
    • 3.5. Opportunities
      • 3.5.1. Untapped Market
    • 3.6. Porter's Five Forces Analysis
      • 3.6.1. Bargaining Power Of Suppliers
      • 3.6.2. Bargaining Power Of Buyers
      • 3.6.3. The Threat From New Entrants
      • 3.6.4. The threat From New Substitutes
      • 3.6.5. Degree Of Competition
    • 3.7. Market Attractiveness Analysis
      • 3.7.1. Market Attractiveness Analysis, by Therapeutics
      • 3.7.2. Market Attractiveness Analysis, by Region
  •  
  • Chapter 4. Global Pneumonia Therapeutics market - Competitive Landscape
    • 4.1. Company Market Share, 2018 (Subject To Data Availability)
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Source Launch
      • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
      • 4.2.4. Research And Development and Regional Expansion
  •  
  • Chapter 5. Global Pneumonia Therapeutics market - Therapeutics Analysis
    • 5.1. Global Pneumonia Therapeutics market: Therapeutics Overview
      • 5.1.1. Global Pneumonia Therapeutics Market Revenue Share, By Therapeutics, 2018 and 2025
    • 5.2. Prevention Vaccines
      • 5.2.1. Global Pneumonia Therapeutics market for Prevention Vaccines, 2016-2025 (USD Billion)
    • 5.3. Treatment Drugs
      • 5.3.1. Global Pneumonia Therapeutics market for Treatment Drugs, 2016-2025 (USD Billion)
  •  
  • Chapter 6. Global Pneumonia Therapeutics market - Distribution Channel Analysis
    • 6.1. Global Pneumonia Therapeutics market: Distribution Channel Overview
      • 6.1.1. Global Pneumonia Therapeutics Market Revenue Share, By Distribution Channel, 2018 and 2025
    • 6.2. Hospital Pharmacy
      • 6.2.1. Global Pneumonia Therapeutics market for Hospital Pharmacy, 2016-2025 (USD Billion)
    • 6.3. Retail Pharmacy
      • 6.3.1. Global Pneumonia Therapeutics market for Retail Pharmacy, 2016-2025 (USD Billion)
    • 6.4. Online Pharmacy
      • 6.4.1. Global Pneumonia Therapeutics market for Online Pharmacy, 2016-2025 (USD Billion)
  •  
  • Chapter 7. Global Pneumonia Therapeutics Market: Regional overview
    • 7.1.. Global Pneumonia Therapeutics Market revenue share, by Region, 2018 and 2025
    • 7.2. North America
      • 7.2.1. North America Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
      • 7.2.2. North America Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.2.3. The U.S.
        • 7.2.3.1. The U.S. Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.2.3.2. The U.S. Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.2.4. Rest of North America
        • 7.2.4.1. Rest of North America Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.2.4.2. Rest of North America Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
    • 7.3. Europe
      • 7.3.1. Europe Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
      • 7.3.2. Europe Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.3.3. UK
        • 7.3.3.1. UK Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.3.3.2. UK Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.3.4. Germany
        • 7.3.4.1. Germany Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.3.4.2. Germany Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.3.5. France
        • 7.3.5.1. France Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.3.5.2. France Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.3.6. Rest of Europe
        • 7.3.6.1. Rest of Europe Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.3.6.2. Rest of Europe Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
      • 7.4.2. Asia Pacific Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.4.3. China
        • 7.4.3.1. China Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.4.3.2. China Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.4.4. Japan
        • 7.4.4.1. Japan Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.4.4.2. Japan Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.4.5. India
        • 7.4.5.1. India Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.4.5.2. India Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.4.6. Rest of Asia Pacific
        • 7.4.6.1. Rest of Asia Pacific Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.4.6.2. Rest of Asia Pacific Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
    • 7.5. Latin America
      • 7.5.1. Latin America Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
      • 7.5.2. Latin America Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.5.3. Brazil
        • 7.5.3.1. Brazil Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.5.3.2. Brazil Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.5.4. Rest of Latin America
        • 7.5.4.1. Rest of Latin America Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.5.4.2. Rest of Latin America Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
    • 7.6. The Middle East and Africa
      • 7.6.1. The Middle East and Africa Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
      • 7.6.2. The Middle East and Africa Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
  •  
  • Chapter 8. Company Profiles
    • 8.1. GlaxoSmithKline
      • 8.1.1. Overview
      • 8.1.2. Financial overview
      • 8.1.3. Therapeutics Portfolio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. Merck & Co.
      • 8.2.1. Overview
      • 8.2.2. Financial Overview
      • 8.2.3. Therapeutics Portfolio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. Novartis AG
      • 8.3.1. Overview
      • 8.3.2. Financial Overview
      • 8.3.3. Therapeutics Portfolio
      • 8.3.4. Business strategy
      • 8.3.5. Recent Developments
    • 8.4. Sanofi
      • 8.4.1. Overview
      • 8.4.2. Financial Overview
      • 8.4.3. Therapeutics Portfolio
      • 8.4.4. Business strategy
      • 8.4.5. Recent Developments
    • 8.5. Eli Lilly and Company
      • 8.5.1. Overview
      • 8.5.2. Financial Overview
      • 8.5.3. Therapeutics Portfolio
      • 8.5.4. Business strategy
      • 8.5.5. Recent Developments
    • 8.6. AstraZeneca
      • 8.6.1. Overview
      • 8.6.2. Financial Overview
      • 8.6.3. Therapeutics Portfolio
      • 8.6.4. Business strategy
      • 8.6.5. Recent Developments
    • 8.7. Pfizer
      • 8.7.1. Overview
      • 8.7.2. Financial Overview
      • 8.7.3. Therapeutics Portfolio
      • 8.7.4. Business strategy
      • 8.7.5. Recent Developments
    • 8.8. Baxter International Inc.
      • 8.8.1. Overview
      • 8.8.2. Financial Overview
      • 8.8.3. Therapeutics Portfolio
      • 8.8.4. Business strategy
      • 8.8.5. Recent Developments
    • 8.9. Lupin Pharmaceuticals Inc.
      • 8.9.1. Overview
      • 8.9.2. Financial Overview
      • 8.9.3. Therapeutics Portfolio
      • 8.9.4. Business strategy
      • 8.9.5. Recent Developments
    • 8.10. Allergan
      • 8.10.1. Overview
      • 8.10.2. Financial Overview
      • 8.10.3. Therapeutics Portfolio
      • 8.10.4. Business strategy
      • 8.10.5. Recent Developments

Table Of Figures

List of Figures 

1. Market Research Process
2. Market Research Methodology
3. Global Pneumonia Therapeutics Market, 2016–2025 (USD Billion)
4. Porter’s Five Forces Analysis
5. Market Attractiveness Analysis by Therapeutics
6. Market Attractiveness Analysis by Distribution Channel
7. Market Attractiveness Analysis by Region
8. Global Pneumonia Therapeutics Market Revenue Share, By Therapeutics, 2016–2025 (USD Billion)
9. Global Pneumonia Therapeutics Market For Prevention Vaccines, 2016–2025 (USD Billion)
10. Global Pneumonia Therapeutics Market For Treatment Drugs, 2016–2025 (USD Billion)
11. Global Pneumonia Therapeutics Market Revenue Share, By Distribution Channel, (USD Billion)
12. Global Pneumonia Therapeutics Market For Hospital Pharmacy, 2016–2025 (USD Billion)
13. Global Pneumonia Therapeutics Market For Retail Pharmacy, 2016–2025 (USD Billion)
14. Global Pneumonia Therapeutics Market For Online Pharmacy, 2016–2025 (USD Billion)
15. North America Pneumonia Therapeutics Market, 2016–2025 (USD Billion)
16. The U.S. Pneumonia Therapeutics Market, 2016–2025 (USD Billion)
17. Rest of North America Pneumonia Therapeutics Market, 2016–2025 (USD Billion)
18. Europe Pneumonia Therapeutics Market, 2016–2025 (USD Billion)
19. UK Pneumonia Therapeutics Market, 2016–2025 (USD Billion)
20. Germany Pneumonia Therapeutics Market, 2016–2025 (USD Billion)
21. France Pneumonia Therapeutics Market, 2016–2025 (USD Billion)
22. Rest of Europe Pneumonia Therapeutics Market, 2016–2025 (USD Billion)
23. Asia Pacific Pneumonia Therapeutics Market, 2016–2025 (USD Billion)
24. China Pneumonia Therapeutics Market, 2016–2025 (USD Billion)
25. Japan Pneumonia Therapeutics Market, 2016–2025 (USD Billion)
26. India Pneumonia Therapeutics Market, 2016–2025 (USD Billion)
27. Rest of Asia Pacific Pneumonia Therapeutics Market, 2016–2025 (USD Billion)
28. Latin America Pneumonia Therapeutics Market, 2016–2025 (USD Billion)
29. Brazil Pneumonia Therapeutics Market, 2016–2025 (USD Billion)
30. Rest of Latin America Pneumonia Therapeutics Market, 2016–2025 (USD Billion)
31. The Middle East and Africa Pneumonia Therapeutics Market, 2016–2025 (USD Billion)


Table Of Tables

List of Tables

1. Global Pneumonia Therapeutics Market: Snapshot
2. Drivers Of The Pneumonia Therapeutics Market: Impact Analysis
3. Restraints For The Pneumonia Therapeutics Market: Impact Analysis
4. North America Pneumonia Therapeutics Market Revenue, By Therapeutics, 2016–2025 (USD Billion)
5. North America Pneumonia Therapeutics Market Revenue, By Distribution Channel, 2016–2025 (USD Billion)
6. The U.S. Pneumonia Therapeutics Market Revenue, By Therapeutics, 2016–2025 (USD Billion)
7. The U.S. Pneumonia Therapeutics Market Revenue, By Distribution Channel, 2016–2025 (USD Billion)
8. Rest of North America Pneumonia Therapeutics Market Revenue, By Therapeutics, 2016–2025 (USD Billion)
9. Rest of North America Pneumonia Therapeutics Market Revenue, By Distribution Channel, 2016–2025 (USD Billion)
10. Europe Pneumonia Therapeutics Market Revenue, By Therapeutics, 2016–2025 (USD Billion)
11. Europe Pneumonia Therapeutics Market Revenue, By Distribution Channel, 2016–2025 (USD Billion)
12. UK Pneumonia Therapeutics Market Revenue, By Therapeutics, 2016–2025 (USD Billion)
13. UK Pneumonia Therapeutics Market Revenue, By Distribution Channel, 2016–2025 (USD Billion)
14. Germany Pneumonia Therapeutics Market Revenue, By Therapeutics, 2016–2025 (USD Billion)
15. Germany Pneumonia Therapeutics Market Revenue, By Distribution Channel, 2016–2025 (USD Billion)
16. France Pneumonia Therapeutics Market Revenue, By Therapeutics, 2016–2025 (USD Billion)
17. France Pneumonia Therapeutics Market Revenue, By Distribution Channel, 2016–2025 (USD Billion)
18. Rest of Europe Pneumonia Therapeutics Market Revenue, By Therapeutics, 2016–2025 (USD Billion)
19. Rest of Europe Pneumonia Therapeutics Market Revenue, By Distribution Channel, 2016–2025 (USD Billion)
20. China Pneumonia Therapeutics Market Revenue, By Therapeutics, 2016–2025 (USD Billion)
21. China Pneumonia Therapeutics Market Revenue, By Distribution Channel, 2016–2025 (USD Billion)
22. Japan Pneumonia Therapeutics Market Revenue, By Therapeutics, 2016–2025 (USD Billion)
23. Japan Pneumonia Therapeutics Market Revenue, By Distribution Channel, 2016–2025 (USD Billion)
24. India Pneumonia Therapeutics Market Revenue, By Therapeutics, 2016–2025 (USD Billion)
25. India Pneumonia Therapeutics Market Revenue, By Distribution Channel, 2016–2025 (USD Billion)
26. Rest of Asia Pacific Pneumonia Therapeutics Market Revenue, By Therapeutics, 2016–2025 (USD Billion)
27. Rest of Asia Pacific Pneumonia Therapeutics Market Revenue, By Distribution Channel, 2016–2025 (USD Billion)
28. Latin America Pneumonia Therapeutics Market Revenue, By Therapeutics, 2016–2025 (USD Billion)
29. Latin America Pneumonia Therapeutics Market Revenue, By Distribution Channel, 2016–2025 (USD Billion)
30. Brazil Pneumonia Therapeutics Market Revenue, By Therapeutics, 2016–2025 (USD Billion)
31. Brazil Pneumonia Therapeutics Market Revenue, By Distribution Channel, 2016–2025 (USD Billion)
32. Rest of Latin America Pneumonia Therapeutics Market Revenue, By Therapeutics, 2016–2025 (USD Billion)
33. Rest of Latin America Pneumonia Therapeutics Market Revenue, By Distribution Channel, 2016–2025 (USD Billion)
34. The Middle East and Africa Pneumonia Therapeutics Market Revenue, By Therapeutics, 2016–2025 (USD Billion)
35. The Middle East and Africa Pneumonia Therapeutics Market Revenue, By Distribution Channel, 2016–2025 (USD Billion)

Methodology

Free Analysis

Pneumonia is an inflammatory condition that affects the air sacs or alveoli in the lungs and may further lead to dry cough, chest pain, fever, breathing trouble, etc. It is generally caused by germs and bacteria and mainly affects the person already suffering from cold and flu. It can be life-threatening for infants, young children, and elderly people. It can be diagnosed with the help of blood tests, X-rays, physical examinations, etc. Vaccination helps in the prevention of pneumonia, whereas patients with severe condition patient need to be hospitalized and treated with oxygen therapy. Generally, antibiotics like quinolones, macrolides, etc. are used for treating pneumonia.

The global pneumonia therapeutics market is growing due to increasing air pollution and rising geriatric population across the globe. Environmental factors are also considered major factors for the growth of pneumonia therapeutics market globally. Various environmental wastes like chemicals catalyze the growth of fungi, virus, and bacteria. These microorganisms cause pneumonia. According to the World Health Organization, more than 1.6 million annual deaths of children under the age of five are caused by pneumonia. However, the lack of awareness among the population about diagnosis and treatment and traditional treatment for pneumonia may restrain the growth of the global pneumonia therapeutics market in the future.

Global Pneumonia Therapeutics Market

Based on therapeutics, the global pneumonia therapeutics market is segmented into prevention vaccines and treatment drugs. The prevention vaccines held the largest market share in terms of revenue in 2018, due to their high efficacy and precautionary effects. The treatment drugs segment is likely to show moderate growth in the years ahead, due to the wide availability of generic forms and growing resistance of antibiotics. Based on the distribution channel, the market is classified into hospital pharmacy, online pharmacy, and retail pharmacy.

By region, North America is expected to witness the highest CAGR over the forecast time period. This growth can be attributed to the increasing air pollution and growing release of hazardous chemicals in the environment. In Europe, the mortality rates for pneumonia are substantially higher in children up to four years and in adults aged 75 or over as compared to other age groups. This growth is mainly due to the increasing geriatric population and lifestyle-related ailments.

Some key participants operating in the global pneumonia therapeutics market include GlaxoSmithKline, Sanofi, Merck & Co. Inc., Novartis AG, Eli Lilly and Company, AstraZeneca, Merck & Co., Pfizer, Baxter International Inc., Allergan, and Lupin Pharmaceuticals Inc., among others.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed